- Home
- SBH vs NVCR Comparison
SBH vs NVCR Comparison
Compare SBH & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SBH | NVCR |
|---|---|---|
| Founded | 1964 | 2000 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2006 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SBH | NVCR |
|---|---|---|
| Price | $14.14 | $12.31 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 6 |
| Target Price | $17.25 | ★ $28.08 |
| AVG Volume (30 Days) | 1.2M | ★ 1.7M |
| Earning Date | 05-11-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.17 | 21.79 |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $3,701,424,000.00 | $655,353,000.00 |
| Revenue This Year | $2.20 | $7.72 |
| Revenue Next Year | $1.82 | $6.74 |
| P/E Ratio | $31.49 | ★ N/A |
| Revenue Growth | N/A | ★ 8.28 |
| 52 Week Low | $7.54 | $9.82 |
| 52 Week High | $17.92 | $20.05 |
Technical Indicators
Market Signals| Indicator | SBH | NVCR |
|---|---|---|
| Relative Strength Index (RSI) | 38.07 | 48.97 |
| Support Level | $14.10 | $10.86 |
| Resistance Level | $15.75 | $13.78 |
| Average True Range (ATR) | 0.54 | 0.78 |
| MACD | -0.16 | -0.09 |
| Stochastic Oscillator | 7.80 | 23.94 |
Price Performance
Historical ComparisonAbout SBH Sally Beauty Holdings Inc. (Name to be changed from Sally Holdings Inc.)
Sally Beauty Holdings Inc is a professional beauty-products retailer based in the United States. The company operates throughout the United States, Puerto Rico, the United Kingdom, Belgium, Canada, Chile, Mexico, Peru, France, Ireland, Spain, Germany, Netherlands, and other geographical regions. The company operates through two business segments: Sally Beauty Supply and Beauty Systems Group. The products offered by the company include hair color and care, hair dryers and hair-styling appliances, nail care, skin care, and others.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.